Enliven Therapeutics, Inc. (ELVN)
49.45
-0.79
(-1.57%)
USD |
NASDAQ |
Sep 18, 16:00
49.45
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics Free Cash Flow : -67.04M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -67.04M |
| March 31, 2026 | -65.60M |
| December 31, 2025 | -70.46M |
| September 30, 2025 | -71.82M |
| June 30, 2025 | -70.76M |
| March 31, 2025 | -74.00M |
| December 31, 2024 | -73.24M |
| September 30, 2024 | -68.53M |
| June 30, 2024 | -72.22M |
| March 31, 2024 | -63.92M |
| December 31, 2023 | -61.42M |
| September 30, 2023 | -60.41M |
| Date | Value |
|---|---|
| June 30, 2023 | -50.96M |
| March 31, 2023 | -46.25M |
| December 31, 2022 | -35.93M |
| September 30, 2022 | -36.93M |
| June 30, 2022 | -41.37M |
| March 31, 2022 | -44.31M |
| December 31, 2021 | -46.78M |
| September 30, 2021 | -42.56M |
| June 30, 2021 | -42.01M |
| March 31, 2021 | -40.91M |
| December 31, 2020 | -37.42M |
| September 30, 2020 | -37.19M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Definium Therapeutics, Inc. | -166.74M |
| Cocrystal Pharma, Inc. | -8.276M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -208.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.53M |
| Cash from Investing (Quarterly) | -441.57M |
| Cash from Financing (Quarterly) | 463.42M |
| Free Cash Flow Per Share (Quarterly) | -0.2815 |
| Free Cash Flow to Equity (Quarterly) | -19.84M |
| Free Cash Flow to Firm (Quarterly) | -18.63M |
| Free Cash Flow Yield | -2.14% |